ANGELA CROUSE: Open Payments
NPI 1306144704 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 13 payments from 7 companies in 2025. Trend: 2023 $186 · 2024 $312 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $268 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| PFIZER INC. | 3 | $55 |
| Abbott Laboratories | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Boston Scientific Corporation | 1 | $18 |
Products named: SAPIEN 3 Ultra RESILIA, LEQVIO, ELIQUIS, CARDIOMEMS, JARDIANCE, VYNDAQEL, CDS - MCT/CEM Monitoring.
Industry payments across IN — which companies pay providers there.
